Advances in classification and targeted therapy of gliomas

P. Wen

doi:10.1016/j.jns.2017.08.121

96| Volume 381, SUPPLEMENT , 28, October 15, 2017

Advances in classification and targeted therapy of gliomas

P. Wen
P. Wen
Correspondence
Corresponding author.
Affiliations
Dana-Farber Cancer Institute, Center For Neuro-Oncology, Boston, USA
Search for articles by this author

DOI:https://doi.org/10.1016/j.jns.2017.08.121

This talk will discuss the 2016 update to the WHO Classification of CNS Tumors as well as the advances in understanding the molecular pathogenesis of gliomas and clinical trials of targeted molecular therapies.

To read this article in full you will need to make a payment

Purchase one-time access:

One-time access price info

For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

Article info

Identification

DOI: https://doi.org/10.1016/j.jns.2017.08.121

Copyright

ScienceDirect

Access this article on ScienceDirect

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Advances in classification and targeted therapy of gliomas

Purchase one-time access:

Subscribe:

Article info

Identification

Copyright

ScienceDirect

Related Articles